Not Feeling Well?
Get your flu and COVID-19 vaccines
Schedule your appointment through MyHealth, call 650-498-9000, or visit your local pharmacy.
Where To Get Care
For life-threatening emergencies, call 911 or go to the Emergency Department.
Express Care
For coughs, sprains, or other issues that can't wait. Open daily. Book same-day, in-person, or video visits.
See clinic details
Monday to Friday, 7 a.m.–7 p.m.
Weekends, 8:30 a.m.–5 p.m.
Primary Care
For preventive care, annual check-ups, referrals to specialty care, screenings, and immunizations.
Or call 650-498-9000
Monday to Friday, 7 a.m.–7 p.m.
Weekends, 8:30 a.m.–5 p.m.
Specialty Care
For consultations and treatments in specific areas of medicine. Referrals needed for select specialties.
Or call 650-498-3333
Available 24/7
FOR REFERRING PHYSICIANS
Interested in referring or transferring a patient?
How to refer
NEED A SECOND OPINION?
Consult with one of our experts from home.
Get a second opinion
We accept most insurance plans. Explore coverage options
It’s Time for Your Mammogram
Detect breast cancer early when it’s most treatable. Find a breast cancer screening near you.
Taking On the Menopause, Breast Cancer Double Whammy
Stanford Medicine gynecologists offer tailored strategies to manage menopause symptoms in breast cancer survivors who can’t use hormone replacement therapy.
A Sunscreen ‘Gamechanger’? What the Science Says About Bemotrizinol
The U.S. Food and Drug Administration finally gave the green light to bemotrizinol. Stanford Medicine dermatologists weigh in.
New Stanford Medicine Magazine Issue: Made to Move
Discover the science and innovations in orthopaedics, from musculoskeletal development to peak performance.
Enhancing Patient Care With AI
Learn how we are using AI to improve patient outcomes.
IN THE NEWS
Stanford University Professor Karl Deisseroth Wins 2026 Nobel Prize in Physiology or Medicine
Karl Deisseroth, MD, PhD, a Stanford University professor of bioengineering and of psychiatry and behavioral sciences, was recognized for his work in optogentics.
IN THE NEWS
A Bleeding-Edge Breakthrough for Blood Cancer Patients
Findings from a Phase 3 trial led by Stanford Medicine and the Stanford Cancer Institute formed the basis for the Food and Drug Administration's approval of Orca-T, a cell therapy that prevents immune overaction. This marks the first approval of a regulatory T cell-based therapy for clinical use.
IN THE NEWS
New Stanford University Center Will Use AI to Tailor Dementia Treatments and Aging Interventions
The National Institute on Aging has awarded Stanford University researchers a $25 million grant to establish a center exploring how artificial intelligence can improve life for the aging population and for people with Alzheimer’s disease-related dementias.
